30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2014 Revenue: Alphatec Spine

4Q14 revenue: $53.6MM, +5% (U.S. $35.7MM, flat; ex-U.S. $17.9MM, +14%; U.S. Biologics +14%)

2014 revenue: $207.0MM, +3% (U.S. $137.1MM, +2%; ex-U.S. $69.9MM, +4%)


  • Estimates global pedicle screw market at ~$4BB, interbody ~$1.5BB (together ~2/3 of global fusion market)
  • Estimates global 2015 lateral market ~$600MM, deformity ~$650MM
  • Completed U.S. beta launch for Arsenal fixation system for degenerative spine in 4Q and full commercial launch in mid-1Q15; gained 50% uptake from new users in beta launch
  • 2015 U.S. launches include 2Q15 Arsenal Cortical Bone Fixation (CBX); beta launch of Battalion titanium-coated PEEK interbody system, to include new disc prep instrumentation; 1Q Brazil launch of Zodiac and ILLICO MIS; 2Q Arsenal degenerative in Japan
  • Seeking to establish new distributor relationships in 8 EU countries in 1H15 to support launch of Zodiac fixation
  • Will focus R&D on lateral and deformity, for 1H16 launches